Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): S$0.04839

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is S$0.04613. In 2023 the company made an earnings per share (EPS) of S$0.02300 a decrease over its 2022 EPS that were of S$0.02546.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2023	S$0.02300	-9.68%
2022	S$0.02546	-83.86%
2021	S$0.16	440.46%
2020	S$0.02918	7.54%
2019	S$0.02713	-70.37%
2018	S$0.09158	254.37%
2017	S$0.02584	41.55%
2016	S$0.01826	2.59%
2015	S$0.01780	17.63%
2014	S$0.01513	45.97%
2013	S$0.01036	16.34%
2012	S$0.008908	93.4%
2011	S$0.004606	-20.02%
2010	S$0.005759	33.16%
2009	S$0.004325	774.72%
2008	S$0.0004945	-79.69%
2007	S$0.002435	58.8%
2006	S$0.001533	-91.05%
2005	S$0.01713	723.97%
2004	S$0.002078	105.48%
2003	S$0.001012	-67.27%
2002	S$0.003090	-8.26%
2001	S$0.003369	17.18%
2000	S$0.002875	0.14%
1999	S$0.002871

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)